These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 22061180)
1. Primer on visual field testing, electroretinography, and other visual assessments for patients treated with vigabatrin. Sergott RC; Westall CA Acta Neurol Scand Suppl; 2011; (192):48-56. PubMed ID: 22061180 [TBL] [Abstract][Full Text] [Related]
5. A lack of clinically apparent vision loss among patients treated with vigabatrin with infantile spasms: The UCLA experience. Schwarz MD; Li M; Tsao J; Zhou R; Wu YW; Sankar R; Wu JY; Hussain SA Epilepsy Behav; 2016 Apr; 57(Pt A):29-33. PubMed ID: 26921595 [TBL] [Abstract][Full Text] [Related]
8. Vigabatrin-induced peripheral visual field defects in patients with refractory partial epilepsy. Sergott RC; Bittman RM; Christen EM; Sagar SM Epilepsy Res; 2010 Dec; 92(2-3):170-6. PubMed ID: 20951555 [TBL] [Abstract][Full Text] [Related]
9. Visual field constriction on vigabatrin. Prescrire Int; 2000 Feb; 9(45):210-1. PubMed ID: 11503799 [TBL] [Abstract][Full Text] [Related]
10. Retinal structure and function in vigabatrin-treated adult patients with refractory complex partial seizures. Sergott RC; Johnson CA; Laxer KD; Wechsler RT; Cherny K; Whittle J; Feng G; Lee D; Isojarvi J Epilepsia; 2016 Oct; 57(10):1634-1642. PubMed ID: 27580566 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of visual field loss following exposure to vigabatrin therapy: a systematic review. Maguire MJ; Hemming K; Wild JM; Hutton JL; Marson AG Epilepsia; 2010 Dec; 51(12):2423-31. PubMed ID: 21070215 [TBL] [Abstract][Full Text] [Related]
12. Which children receive vigabatrin? Characteristics of pediatric patients enrolled in the mandatory FDA registry. Pellock JM; Faught E; Foroozan R; Sergott RC; Shields WD; Ziemann A; Lee D; Dribinsky Y; Torri S; Othman F; Isojarvi J Epilepsy Behav; 2016 Jul; 60():174-180. PubMed ID: 27208827 [TBL] [Abstract][Full Text] [Related]
13. Electrophysiologic evaluation of a patient with peripheral visual field contraction associated with vigabatrin. Ruether K; Pung T; Kellner U; Schmitz B; Hartmann C; Seeliger M Arch Ophthalmol; 1998 Jun; 116(6):817-9. PubMed ID: 9639460 [No Abstract] [Full Text] [Related]
14. Does vigabatrin treatment for infantile spasms cause visual field defects? An international multicentre study. Riikonen R; Rener-Primec Z; Carmant L; Dorofeeva M; Hollody K; Szabo I; Krajnc BS; Wohlrab G; Sorri I Dev Med Child Neurol; 2015 Jan; 57(1):60-7. PubMed ID: 25145415 [TBL] [Abstract][Full Text] [Related]
15. Measuring field loss in children administered vigabatrin: a problem in search of a solution. Good WV J AAPOS; 2011 Oct; 15(5):411-2. PubMed ID: 22108349 [No Abstract] [Full Text] [Related]
16. [Visual field changes secondary to vigabatrin treatment]. Mauri-Llerda JA; Iñiguez C; Tejero-Juste C; Santos-Lasaosa S; Escalza-Cortina I; Ascaso-Puyuelo J; Abad-Alegría F; Morales-Asín F Rev Neurol; 2000 Dec 16-31; 31(12):1104-8. PubMed ID: 11205539 [TBL] [Abstract][Full Text] [Related]
17. Infantile spasms and vigabatrin. Visual field defects may be permanent. Lhatoo SD; Sander JW BMJ; 1999 Jan; 318(7175):57. PubMed ID: 10068225 [No Abstract] [Full Text] [Related]
19. Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile. Camposano SE; Major P; Halpern E; Thiele EA Epilepsia; 2008 Jul; 49(7):1186-91. PubMed ID: 18479386 [TBL] [Abstract][Full Text] [Related]
20. Vigabatrin-associated visual field loss. Fecarotta C; Sergott RC Int Ophthalmol Clin; 2012; 52(3):87-94, xii. PubMed ID: 22668542 [No Abstract] [Full Text] [Related] [Next] [New Search]